NASDAQ: ACRV - Acrivon Therapeutics, Inc.

छह महीने के लिए लाभप्रदता: -2.63%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Acrivon Therapeutics, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates.

अधिक जानकारी
Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in a potentially registrational Phase 2 trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response and cell cycle regulation pathways, such as WEE1, a protein kinase and PKMYT1, a protein serine/threonine kinase. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2022-11-15
ISIN US0048901096
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.acrivon.com
Цена ао 6.33
प्रति दिन मूल्य परिवर्तन: -4.36% (6.19)
प्रति सप्ताह मूल्य परिवर्तन: -11.77% (6.71)
प्रति माह मूल्य परिवर्तन: -21.28% (7.52)
3 महीने में कीमत में बदलाव: -17.32% (7.16)
छह महीने में कीमत में बदलाव: -2.63% (6.08)
प्रति वर्ष मूल्य परिवर्तन: +20.33% (4.92)
3 वर्षों में मूल्य परिवर्तन: 0% (5.92)
5 वर्षों में मूल्य परिवर्तन: 0% (5.92)
10 वर्षों में मूल्य परिवर्तन: 0% (5.92)
वर्ष की शुरुआत से मूल्य परिवर्तन: -30.35% (8.5)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0 0
P/BV 0.9109 9
P/E 0 0
EV/EBITDA -1.18 0
कुल: 3.63

क्षमता

नाम अर्थ श्रेणी
ROA, % -43.68 0
ROE, % -49.83 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.0696 10
कुल: 9.2

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 0 0
लाभप्रदता Ebitda, % 1770.38 10
लाभप्रदता EPS, % 564.2 10
कुल: 8
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
RA Capital Management, L.P. 4810508 21.25
Perceptive Advisors LLC 3007858 13.29
Sands Capital Ventures, LLC 1652605 7.3
Citadel Advisors Llc 1649659 7.29
Wellington Management Group, LLP 888130 3.92
Marshall Wace LLP 597469 2.64
Blackrock Inc. 565832 2.5
Vanguard Group Inc 475977 2.1
NEA Management Company, LLC 430252 1.9
Federated Hermes, Inc. 226375 1

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
Range Cancer Therapeutics ETF 2.03779 47.24 0.11955
iShares Micro-Cap ETF 0.02284 17.09 1.54048
Avantis U.S Small Cap Equity ETF 0.00853 27.77 1.68271
Schwab U.S. Small-Cap ETF 0.00415 17.47 1.51433
ProShares UltraPro Russell2000 0.0019 89.82 1.47873
ProShares Hedge Replication ETF 0.00053 5.92 1.47892
Schwab U.S. Broad Market ETF 0.00053 24.86 1.43354
Vanguard Russell 2000 ETF 0 17.16 1.48801
Vanguard Russell 3000 ETF 0 31.87 1.43817



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Dr. Peter Blume-Jensen M.D., Ph.D. Co-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer 977.7k 1963 (62 वर्ष)
Ms. Kristina Masson M.B.A., Ph.D. Co-Founder, Executive VP of Business Operations, Site Head, Treasurer, Secretary & Director 739.78k 1981 (44 वर्ष)
Mr. Rasmus Holm-Jorgensen Chief Financial Officer 1M 1972 (53 वर्ष)
Dr. Eric J. Devroe Ph.D. Chief Operating Officer 614.78k 1979 (46 साल)
Ms. Katharine Peterson CPA Vice President of Finance & Accounting N/A
Dr. Adam D. Levy M.B.A., Ph.D. Senior VP and Head of Investor Relations & Corporate Affairs N/A
Mr. Bruce Close Vice President of Quality & Compliance N/A
Ms. Mary-Alice Miller J.D. Chief Legal Officer 587.11k 1974 (51 वर्ष)
Ms. Parvin Miah VP & Head of Human Resources N/A
Dr. Erick Gamelin M.D., Ph.D. Chief Development Officer 480.72k 1958 (67 साल)

पता: United States, Watertown. MA, 480 Arsenal Way - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.acrivon.com